Crossmark

Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment

Crossref DOI link: https://doi.org/10.1186/s40064-015-0802-4

Published Online: 2015-01-23

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Blaes, Anne

Duprez, Daniel

Defor, Todd

Shanley, Ryan

Beckwith, Heather

Haddad, Tufia

Potter, David

Yee, Douglas

Sanghavi, Kinjal

Jacobson, Pamala
License Information

License valid from 2015-01-23
More Information

Article History

Received: 7 January 2015

Accepted: 8 January 2015

First Online: 23 January 2015